Mode of Action: Inhibition of Histone Deacetylase, Altering WNT-Dependent Gene Expression, and Regulation of Beta-Catenin—Developmental Effects of Valproic Acid

Valproic acid (VPA) has long been known to cause spina bifida, a neural tube defect, and other effects in fetuses of women treated with this drug. Toxicological tests in laboratory mice and rats at human therapeutic doses also show neural tube and other defects. Studies show that VPA alters Wnt signaling in human and animal cells, inducing Wnt-dependent gene expression at doses that cause developmental effects. Structural analogues of VPA that do not have this effect on Wnt signaling do not cause developmental effects. Similarly, Trichostatin A, a compound that mimics VPA in its effects on Wnt gene expression, also causes similar developmental effects. Alteration of Wnt signaling is empirically well supported as the postulated mode of action (MOA) for VPA's developmental effects in animals. VPA causes alteration of Wnt signaling in both human and animal cells systems at the same dose levels. The correspondence of effects on signaling and of effects on development in animals and humans supports the view that alteration of Wnt signaling is a relevant MOA in humans.

[1]  H. Nau,et al.  Valproic acid-induced spina bifida: a mouse model. , 1992, Teratology.

[2]  H. Nau,et al.  Valproic acid-induced neural tube defects: reduction by folinic acid in the mouse. , 1987, Life sciences.

[3]  W. Scott,et al.  Strain differences in the teratogenicity induced by sodium valproate in cultured mouse embryos. , 1988, Teratology.

[4]  M. Szyf,et al.  Valproate Induces Replication-independent Active DNA Demethylation* , 2003, Journal of Biological Chemistry.

[5]  H. Nau,et al.  Evaluation of valproic acid (VPA) developmental toxicity and pharmacokinetics in Sprague-Dawley rats. , 1988, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[6]  R. Ohlsson,et al.  The paternal allele of the H19 gene is progressively silenced during early mouse development: the acetylation status of histones may be involved in the generation of variegated expression patterns. , 1998, Development.

[7]  W. Drevets.  Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders , 2001, Current Opinion in Neurobiology.

[8]  Í. Lopes-Cendes,et al.  Repeated Neural Tube Defects and Valproate Monotherapy Suggest a Pharmacogenetic Abnormality , 2001, Epilepsia.

[9]  R. Blaheta,et al.  Valproate and valproate-analogues: potent tools to fight against cancer. , 2002, Current medicinal chemistry.

[10]  R. Goold,et al.  Glycogen synthase kinase 3 β phosphorylation of microtubule-associated protein 1 B regulates the stability of microtubules in growth cones , 1999 .

[11]  H. Nau,et al.  Effect of supplementation with folinic acid, vitamin B6, and vitamin B12 on valproic acid-induced teratogenesis in mice. , 1992, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[12]  M. Guenther,et al.  Histone Deacetylase Is a Direct Target of Valproic Acid, a Potent Anticonvulsant, Mood Stabilizer, and Teratogen* , 2001, The Journal of Biological Chemistry.

[13]  E A Harvey,et al.  The teratogenicity of anticonvulsant drugs. , 2001, The New England journal of medicine.

[14]  E. Robert,et al.  MATERNAL VALPROIC ACID AND CONGENITAL NEURAL TUBE DEFECTS , 1982, The Lancet.

[15]  H. Manji,et al.  PKC, MAP kinases and the bcl-2 family of proteins as long-term targets for mood stabilizers , 2002, Molecular Psychiatry.

[16]  A. Harwood,et al.  A common mechanism of action for three mood-stabilizing drugs , 2002, Nature.

[17]  Husseini K. Manji,et al.  The Wnt Signaling Pathway in Bipolar Disorder , 2002, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[18]  P. S. Klein,et al.  Lithium and valproic acid: parallels and contrasts in diverse signaling contexts. , 2002, Pharmacology & therapeutics.

[19]  H. Nau,et al.  Diurnal variation of folate concentrations in mouse embryo and plasma: the protective effect of folinic acid on valproic-acid-induced teratogenicity is time dependent. , 1991, Reproductive toxicology.

[20]  R. Kavlock,et al.  Developmental toxicity and structure-activity relationships of aliphatic acids, including dose-response assessment of valproic acid in mice and rats. , 1994, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[21]  Matthias Mann,et al.  Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathway. , 2002, Genes & development.

[22]  B. Wlodarczyk,et al.  Effect of sodium valproate on rat embryo development in vitro , 2000 .

[23]  S. Dial,et al.  Effect of supplemental folic acid on valproic acid-induced embryotoxicity and tissue zinc levels in vivo. , 1995, Teratology.

[24]  S. Schneider.  Valproic acid , 1980, The Western journal of medicine.

[25]  Leah C. Fuller,et al.  Neural crest cell motility in valproic acid. , 2002, Reproductive toxicology.

[26]  James R. Woodgett,et al.  Lithium inhibits glycogen synthase kinase-3 activity and mimics Wingless signalling in intact cells , 1996, Current Biology.

[27]  R. Moon,et al.  The axis-inducing activity, stability, and subcellular distribution of beta-catenin is regulated in Xenopus embryos by glycogen synthase kinase 3. , 1996, Genes & development.

[28]  B. Thisse,et al.  The molecular nature of the zebrafish tail organizer , 2003, Nature.

[29]  Karen Cleverley,et al.  Valproate Regulates GSK-3-Mediated Axonal Remodeling and Synapsin I Clustering in Developing Neurons , 2002, Molecular and Cellular Neuroscience.

[30]  H. Nau,et al.  Teratogenic effects of sodium valproate in mice and rats at midgestation and at term. , 1996, Teratogenesis, carcinogenesis, and mutagenesis.

[31]  Ajamete Kaykas,et al.  WNT and β-catenin signalling: diseases and therapies , 2004, Nature Reviews Genetics.

[32]  R. Padmanabhan,et al.  Amelioration of sodium valproate‐induced neural tube defects in mouse fetuses by maternal folic acid supplementation during gestation , 2003, Congenital anomalies.

[33]  E. Fuchs,et al.  Links between signal transduction, transcription and adhesion in epithelial bud development , 2003, Nature.

[34]  Hsien-yu Wang,et al.  Wnt Signaling, Ca2+, and Cyclic GMP: Visualizing Frizzled Functions , 2003, Science.

[35]  G. Zampino,et al.  Teratogenic Effects of Antiepileptic Drugs: Use of an International Database on Malformations and Drug Exposure (MADRE) , 2000, Epilepsia.

[36]  H. Kubinyi,et al.  Medicinal Chemistry , 1963, Nature.

[37]  A. Hall,et al.  Axonal Remodeling and Synaptic Differentiation in the Cerebellum Is Regulated by WNT-7a Signaling , 2000, Cell.

[38]  J. Wallingford,et al.  Neural tube closure requires Dishevelled-dependent convergent extension of the midline , 2002, Development.

[39]  J. Morrow,et al.  Failure of periconceptual folic acid to prevent a neural tube defect in the offspring of a mother taking sodium valproate , 1999, Seizure.

[40]  J. Nadeau,et al.  A mouse model for valproate teratogenicity: parental effects, homeotic transformations, and altered HOX expression. , 2000, Human molecular genetics.

[41]  Ralf J. Sommer,et al.  The evolution of signalling pathways in animal development , 2003, Nature Reviews Genetics.

[42]  G. Varela-Moreiras,et al.  Impaired methionine synthesis and hypomethylation in rats exposed to valproate during gestation , 1999, Neurology.

[43]  H. Nau,et al.  Methotrexate increases valproic acid-induced developmental toxicity, in particular neural tube defects in mice. , 1992, Teratogenesis, carcinogenesis, and mutagenesis.

[44]  O. Pourquié.  The Segmentation Clock: Converting Embryonic Time into Spatial Pattern , 2003, Science.

[45]  J. Craig,et al.  Strain-dependent alterations in the expression of folate pathway genes following teratogenic exposure to valproic acid in a mouse model. , 1997, American journal of medical genetics.

[46]  R. Nusse,et al.  Wnt signaling: a common theme in animal development. , 1997, Genes & development.

[47]  M. Peifer,et al.  Wnt signaling in oncogenesis and embryogenesis--a look outside the nucleus. , 2000, Science.

[48]  E. Cuppen,et al.  The Wnt/β-catenin pathway regulates cardiac valve formation , 2003, Nature.

[49]  K. Sano,et al.  Valproic acid induces apoptosis in human leukemia cells by stimulating both caspase-dependent and -independent apoptotic signaling pathways. , 2002, Leukemia research.

[50]  M. Sztajnkrycer.  Valproic Acid Toxicity: Overview and Management , 2002, Journal of toxicology. Clinical toxicology.

[51]  H. Nau,et al.  Alteration of embryonic folate metabolism by valproic acid during organogenesis: implications for mechanism of teratogenesis. , 1992, Neurology.

[52]  M. Raichle,et al.  Subgenual prefrontal cortex abnormalities in mood disorders , 1997, Nature.

[53]  P. Salinas,et al.  WNT-7a induces axonal remodeling and increases synapsin I levels in cerebellar neurons. , 1997, Developmental biology.

[54]  C. Niehrs,et al.  A morphogen gradient of Wnt/beta-catenin signalling regulates anteroposterior neural patterning in Xenopus. , 2001, Development.

[55]  M. Scott,et al.  Wnt and TGFbeta signals subdivide the AbdA Hox domain during Drosophila mesoderm patterning. , 1998, Development.

[56]  Xiaohua Li,et al.  Glycogen synthase kinase-3beta, mood stabilizers, and neuroprotection. , 2002, Bipolar disorders.